-
Daclatasvir Dihydrochloride
API’s Name Indication Specification US DMF EU DMF CEP Daclatasvir Dihydrochloride HCV In-House √ -
Doxycycline Monohydrate
API’s Name Indication Specification US DMF EU DMF CEP Doxycycline Mono Antibiotics USP/EP 18959 √ -
Doxycycline Hyclate
API’s Name Indication Specification US DMF EU DMF CEP Doxycycline Hyclate Antibiotics USP/EP 13771 √ -
Canagliflozin
API’s Name Indication Specification US DMF EU DMF CEP Canagliflozin Type 2 diabetes In-House √ -
Chlorothiazide
API’s Name Indication Specification US DMF EU DMF CEP Chlorothiazide Diuretics USP/EP -
Bictegravir 1611493-60-7
API’s Name Indication Innovator Patent Expiry Date(The U.S) Bictegravir 1611493-60-7 HIV-1 infection Gilead Sciences Dec. 19, 2033 -
Baloxavir Marboxil 1985606-14-1
API’s Name Indication Innovator Patent Expiry Date(The U.S) Baloxavir Marboxil 1985606-14-1 Influenza Shionogi & Roche Sep.21,2031 -
Agomelatine
API’s Name Indication Specification US DMF EU DMF CEP Agomelatine Depression In-House √ -
Atorvastatin Calcium
API’s Name Indication Specification US DMF EU DMF CEP Atorvastatin Calcium Hypercholesterolemia In-House/CEP 29057 √ CEP 2015-034